DIA506.85-0.04 -0.01%
SPY754.36+3.90 0.52%
QQQ735.91+6.46 0.88%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·02/05/2026 12:05:40
Listen to the news

Gainers

  • CytoMed Therapeutics (NASDAQ:GDTC) shares increased by 27.1% to $1.08 during Thursday's pre-market session. The market value of their outstanding shares is at $9.9 million.
  • Anbio Biotechnology (NASDAQ:NNNN) stock increased by 18.15% to $27.21. The market value of their outstanding shares is at $1.0 billion.
  • ALX Oncology Holdings (NASDAQ:ALXO) shares moved upwards by 16.41% to $2.34. The company's market cap stands at $263.7 million.
  • Nexalin Technology (NASDAQ:NXL) stock moved upwards by 16.19% to $0.66. The market value of their outstanding shares is at $10.5 million.
  • Can Fite Biopharma (AMEX:CANF) shares moved upwards by 15.34% to $4.66. The company's market cap stands at $5.2 million.
  • Align Technology (NASDAQ:ALGN) shares moved upwards by 10.43% to $178.13. The company's market cap stands at $11.6 billion. As per the press release, Q4 earnings came out yesterday.

Losers

  • ENDRA Life Sciences (NASDAQ:NDRA) shares decreased by 11.8% to $3.43 during Thursday's pre-market session. The market value of their outstanding shares is at $4.5 million.
  • Omnicell (NASDAQ:OMCL) shares decreased by 11.12% to $41.5. The company's market cap stands at $2.1 billion. As per the press release, Q4 earnings came out today.
  • Agape ATP (NASDAQ:ATPC) shares declined by 9.05% to $0.08. The market value of their outstanding shares is at $4.2 million.
  • TuHURA Biosciences (NASDAQ:HURA) shares fell 8.93% to $0.42. The market value of their outstanding shares is at $26.1 million.
  • Accuray (NASDAQ:ARAY) shares fell 7.82% to $0.7. The market value of their outstanding shares is at $85.7 million. As per the press release, Q2 earnings came out yesterday.
  • Tempest Therapeutics (NASDAQ:TPST) shares decreased by 7.57% to $2.2. The company's market cap stands at $11.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.